POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » August 2006

What's That Mean?
(just double-click it!)

NEW! If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:


Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


email print

August 30, 2006

Liver Disease Is Leading Cause of Death
(Reuters Health)

August 30, 2006 (Reuters Health) - In the United States, Europe and Australia, the leading cause of non-AIDS mortality is liver-related, a European consortium reports in the Archives of Internal Medicine.

In the August 14/28 issue, findings of the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group, led by Dr. Rainer Weber of University Hospital in Zurich, are presented for 23,441 HIV infected persons followed for 3.5 years, or a total of 76,893 person-years.

There were 1246 (5.3%) deaths from all causes. Of these deaths, 14.5% were liver-related. Among patients who died of liver-related causes, 66.1% had hepatitis C (HCV) infection, 16.1% had hepatitis B (HBV) infection and 7.1% were co-infected with both viruses.

Risk factors for liver-related deaths in HIV in order of degree of risk were lower CD4 cell counts, HCV infection, active HBV infection, intravenous drug use and older age.

The relative risk of death for those with a CD4 count below 50 cells per microliter compared with those with CD4 counts higher than 500 cells per microliter was 16.1. Relative risk of death was 6.7 with HCV RNA levels that were lowest compared to highest relative risk was 3.7 with active HBV infection, and risk of liver-related deaths were doubled with intravenous drug use.

The D:A:D Study Group writes that "the strong association between immunodeficiency and an elevated risk of liver-related deaths underlines the importance of HIV strategies that prevent immunodeficiency." The investigators conclude that studies are needed to determine the value of starting combination antiretroviral therapy in patients at risk of liver-related death.



Copyright © 2006 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

email print


[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Community
Advocacy
Job Listings
Events Calendar
Starting Treatment
My Cool Tools


    jeri33415
    west palm beach
    Florida


    Muzungu
    Granada Hills, SFV
    California


    4everdreamer
    fort lauderdale
    Florida


    Dreaming
    Montgomery County
    Maryland
Click here to join POZ Personals!
Talk to Us
Poll
Should medical marijuana be legal nationwide?
Yes
No

Survey
What Would You Do to End AIDS?

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.